Efficacy of antiviral compounds in human herpesvirus-6–infected glial cells

References

• Ablashi D V, Salahuddin S Z, Josephs S F, Imam F, Lusso P, Gallo R C, Hung C, Lemp J, Markham P D. HBLV (or HHV-6) in human cell lines. Nature 1987; 329: 207, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, Jacobson S. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J NeuroVirol 2005; 11: 384–394, [INFOTRIEVE], [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Akhyani N, Berti R, Brennan M B, Soldan S S, Eaton J M, McFarland H F, Jacobson S. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000; 182: 1321–1325, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bethge W, Beck R, Jahn G, Mundinger P, Kanz L, Einsele H. Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1245–1248, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Birnbaum T, Padovan C S, Sporer B, Rupprecht T A, Ausserer H, Jaeger G, Pfister H W. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis 2005; 40: 887–889, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burns W H, Sandford G R. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 1990; 162: 634–637, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: an emerging pathogen. Emerg Infect Dis 1999; 5: 353–566, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Caserta M T, Hall C B, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein L G. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170: 1586–1589, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cermelli C, Berti R, Soldan S S, Mayne M, D'Ambrosia J M, Ludwin S K, Jacobson S. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 2003; 187: 1377–1387, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Challoner P B, Smith K T, Parker J D, MacLeod D L, Coulter S N, Rose T M, Schultz E R, Bennett J L, Garber R L, Chang M, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92: 7440–7444, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cuomo L, Trivedi P, Cardillo M R, Gagliardi F M, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001; 63: 45–51, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Bolle L, Andrei G, Snoeck R, Zhang Y, Van Lommel A, Otto M, Bousseau A, Roy C, De Clercq E, Naesens L. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem Pharmacol 2004; 67: 325–336, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005a; 18: 217–245, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Bolle L, Van Loon J, De Clercq E, Naesens L. Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 2005b; 75: 76–85, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• De Clercq E. Antiviral drug discovery and development: where chemistry meets with biomedicine. Antiviral Res 2005; 67: 56–75, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Denes E, Magy L, Pradeau K, Alain S, Weinbreck P, Ranger-Rogez S. Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg Infect Dis 2004; 10: 729–731, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11(Suppl 2)105A–111A, [INFOTRIEVE], [CSA]
   Google Scholar
• Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss J D, Cogen P, Gaillard W D, Sato S, Theodore W H, Jacobson S. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 2003; 61: 1405–1411, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, Major E O, Jacobson S. Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 2005; 79: 9439–9448, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Flebbe-Rehwaldt L M, Wood C, Chandran B. Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J Virol 2000; 74: 11040–11054, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ghedin E, Pumfery A, de la Fuente C, Yao K, Miller N, Lacoste V, Quackenbush J, Jacobson S, Kashanchi F. Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis. Retrovirology 2004; 1: 10, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• He J, McCarthy M, Zhou Y, Chandran B, Wood C. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996; 70: 1296–1300, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hengge U R, Brockmeyer N H, Malessa R, Ravens U, Goos M. Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother 1993; 37: 1010–1014, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Isaacson E, Glaser C A, Forghani B, Amad Z, Wallace M, Armstrong R W, Exner M M, Schmid S. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005; 40: 890–893, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999; 73: 8053–8063, [INFOTRIEVE], [CSA]
   Google Scholar
• Janelle M E, Flamand L. Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6. Arch Virol 2006; 51: 1603–1614, [CROSSREF], [CSA]
   Google Scholar
• Kimberlin D W, Whitley R J. Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J NeuroVirol 1998; 4: 474–485, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Knox K K, Harrington D P, Carrigan D R. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995; 45: 288–292, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Maeda Y, Teshima T, Yamada M, Harada M. Reactivation of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Leuk Lymphoma 2000; 39: 229–239, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Manichanh C, Grenot P, Gautheret-Dejean A, Debre P, Huraux J M, Agut H. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 2000; 40: 135–140, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Maschke M, Kastrup O, Diener H C. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 2002; 16: 303–315, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988; 10(Suppl 3)S490–S494, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Mirandola P, Menegazzi P, Merighi S, Ravaioli T, Cassai E, Di Luca D. Temporal mapping of transcripts in herpesvirus 6 variants. J Virol 1998; 72: 3837–3844, [INFOTRIEVE], [CSA]
   Google Scholar
• Mookerjee B P, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20: 905–906, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Niiya H, Azuma T, Jin L, Uchida N, Inoue A, Hasegawa H, Fujita S, Tohyama M, Hashimoto K, Yasukawa M. Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells. J Gen Virol 2004; 85: 2639–2642, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Nitsche A, Muller C W, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W. Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 2001; 183: 130–133, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Opsahl M L, Kennedy P G. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005; 128: 516–527, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Opsahl M L, Kennedy P G. Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J Neurol Sci 2006; 240: 37–44, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Oster B, Hollsberg P. Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol 2002; 76: 7578–7586, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transplant Infect Dis 2002; 4: 10–16, [CROSSREF], [CSA]
   Google Scholar
• Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995; 28: 343–357, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Salahuddin S Z, Ablashi D V, Markham P D, Josephs S F, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596–601, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schneider U, Schwemmle M, Staeheli P. Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A 2005; 102: 3441–3446, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Soldan S S, Berti R, Salem N, Secchiero P, Flamand L, Calabresi P A, Brennan M B, Maloni H W, McFarland H F, Lin H C, Patnaik M, Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3: 1394–1397, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065–1067, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yao K, Mandel M, Akyani N, Maynard K, Sengamalay N, Fotheringham J, Ghedin E, Kashanchi F, Jacobson S. Differential HHV-6A gene expression in T cells and primary human astrocytes based on multi-virus array analysis. Glia 2006; 53: 789–798, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Yoshida H, Matsunaga K, Ueda T, Yasumi M, Ishikawa J, Tomiyama Y, Matsuzawa Y. Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int J Hematol 2002; 75: 421–425, [INFOTRIEVE], [CSA]
   Google Scholar
• Yoshikawa T, Asano Y, Akimoto S, Ozaki T, Iwasaki T, Kurata T, Goshima F, Nishiyama Y. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 2002; 66: 497–505, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar